Nonsyndromic genetic hearing loss: genes and variants
Explore variant evidence for Nonsyndromic genetic hearing loss across 8 analyzed proteins (GJB2, OTOF, TMC1, MYO7A, MYO15A and 3 more). Linked ClinVar records include 51 pathogenic or likely pathogenic variants, 20 variants of uncertain significance and 14 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Nonsyndromic genetic hearing loss
GJB2: Gap junction beta-2 protein
Its connexin 26 channels support potassium and metabolite recycling within the cochlea and communication across epithelial gap junctions. Biallelic pathogenic variants are among the most common causes of congenital nonsyndromic hearing loss, while dominant variants can cause syndromic deafness with skin disease.
28 ClinVar pathogenic / likely pathogenic and 20 uncertain variants in GJB2 have source records linked to Nonsyndromic genetic hearing loss. Association strength is not clinical gene validity.
OTOF: Otoferlin
It couples calcium entry to synaptic-vesicle fusion at inner hair-cell ribbon synapses, enabling rapid transmission of acoustic signals to the auditory nerve. Biallelic loss-of-function variants cause DFNB9 auditory neuropathy or nonsyndromic sensorineural hearing loss.
8 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in OTOF have source records linked to Nonsyndromic genetic hearing loss. Association strength is not clinical gene validity.
TMC1: Transmembrane channel-like protein 1
A pore-forming component of the mechanotransduction channel at the tips of cochlear hair-cell stereocilia. Variants can cause inherited hearing loss.
4 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in TMC1 have source records linked to Nonsyndromic genetic hearing loss. Association strength is not clinical gene validity.
MYO7A: Unconventional myosin-VIIa
Its actin-based motor supports stereocilia organization in inner-ear hair cells and transport processes in retinal cells. Biallelic pathogenic variants cause Usher syndrome type 1B, while other alleles can cause nonsyndromic hearing loss.
4 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in MYO7A have source records linked to Nonsyndromic genetic hearing loss. Association strength is not clinical gene validity.
MYO15A: Unconventional myosin-XV
An actin-based motor protein needed to build and maintain the stereocilia of inner-ear hair cells. Variants can cause severe nonsyndromic hearing loss.
3 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MYO15A have source records linked to Nonsyndromic genetic hearing loss. Association strength is not clinical gene validity.
TECTA: Alpha-tectorin
Its extracellular matrix organizes the tectorial membrane that mechanically couples sound-induced motion to cochlear hair cells. Dominant or recessive pathogenic variants cause nonsyndromic hearing loss, with characteristic frequency patterns depending on the affected region.
2 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in TECTA have source records linked to Nonsyndromic genetic hearing loss. Association strength is not clinical gene validity.
KCNQ4: Potassium voltage-gated channel subfamily KQT member 4
Its potassium conductance is crucial for electrical homeostasis in cochlear outer hair cells and auditory pathways. Dominant pathogenic variants are a well-established cause of progressive nonsyndromic sensorineural hearing loss, classically DFNA2.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KCNQ4 have source records linked to Nonsyndromic genetic hearing loss. Association strength is not clinical gene validity.
MYO6: Unconventional myosin-VI
A reverse-direction actin motor involved in intracellular transport and organization of hair-cell stereocilia. Variants can cause inherited hearing loss.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MYO6 have source records linked to Nonsyndromic genetic hearing loss. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): COL4A5, CLDN14 and SLC26A4.
ClinVar pathogenic and likely pathogenic variants linked to Nonsyndromic genetic hearing loss
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GJB2 M195T | 195 | Transmembrane | Pathogenic / likely pathogenic (★★★) |
| GJB2 M1R | 1 | Pathogenic / likely pathogenic (★★★) | |
| GJB2 M1T | 1 | Pathogenic / likely pathogenic (★★★) | |
| GJB2 M1I | 1 | Pathogenic / likely pathogenic (★★★) | |
| GJB2 M195V | 195 | Transmembrane | Pathogenic / likely pathogenic (★★★) |
| GJB2 M1L | 1 | Pathogenic / likely pathogenic (★★★) | |
| GJB2 V37I | 37 | Transmembrane | Pathogenic / likely pathogenic (★★★) |
| GJB2 V37A | 37 | Transmembrane | Pathogenic / likely pathogenic (★★★) |
| GJB2 L76P | 76 | Transmembrane | Pathogenic / likely pathogenic (★★★) |
| GJB2 K188R | 188 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| KCNQ4 G285S | 285 | Segment H5 | Pathogenic / likely pathogenic (★★★) |
| GJB2 M1V | 1 | Pathogenic / likely pathogenic (★★★) | |
| OTOF R1792C | 1792 | C2 7 | Pathogenic / likely pathogenic (★★★) |
| GJB2 M34T | 34 | Transmembrane | Pathogenic / likely pathogenic (★★★) |
| KCNQ4 W275C | 275 | Segment H5 | Pathogenic / likely pathogenic (★★★) |
| GJB2 G12C | 12 | Intramembrane | Pathogenic / likely pathogenic (★★★) |
| GJB2 W172C | 172 | Extracellular | Pathogenic / likely pathogenic (★★★) |
| MYO15A V1400M | 1400 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A R395C | 395 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A S617P | 617 | Myosin motor | Pathogenic / likely pathogenic (★★★) |
| MYO7A R853H | 853 | IQ 5 | Pathogenic / likely pathogenic (★★★) |
| MYO7A A1288P | 1288 | FERM 1 | Pathogenic / likely pathogenic (★★★) |
| OTOF E1700Q | 1700 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| MYO15A I2113F | 2113 | MyTH4 1 | Pathogenic / likely pathogenic (★★★) |
| GJB2 S19T | 19 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
| GJB2 A40E | 40 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 I35S | 35 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 A40G | 40 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| OTOF G541S | 541 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB2 Q80P | 80 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 H100L | 100 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB2 V178A | 178 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB2 R184Q | 184 | Extracellular | Pathogenic / likely pathogenic (★★) |
| OTOF R1792H | 1792 | C2 7 | Pathogenic / likely pathogenic (★★) |
| GJB2 I20T | 20 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| OTOF R1856Q | 1856 | C2 7 | Pathogenic / likely pathogenic (★★) |
| TECTA R2021H | 2021 | ZP | Pathogenic / likely pathogenic (★★) |
| GJB2 G130V | 130 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| OTOF I1573T | 1573 | C2 6 | Pathogenic / likely pathogenic (★★) |
| GJB2 G109V | 109 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| OTOF P490R | 490 | C2 3 | Pathogenic / likely pathogenic (★★) |
| TMC1 G197R | 197 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| MYO15A R2298Q | 2298 | Tail | Pathogenic / likely pathogenic (★★) |
| TMC1 I266T | 266 | Extracellular | Pathogenic / likely pathogenic (★★) |
| TMC1 R389Q | 389 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 R75Q | 75 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GJB2 R75W | 75 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GJB2 A88G | 88 | Transmembrane | Pathogenic / likely pathogenic (★) |
| OTOF L517P | 517 | C2 3 | Pathogenic / likely pathogenic (★) |
| TECTA R1890C | 1890 | ZP | Pathogenic / likely pathogenic (★) |
| TMC1 Y259C | 259 | Extracellular | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Nonsyndromic genetic hearing loss
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GJB2 M195I | 195 | Transmembrane | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; M195T at the same position is pathogenic; REVEL 0.928 |
Which prediction tools work for Nonsyndromic genetic hearing loss
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 93 out of 100
- CADD: 90 out of 100
- MetaSVM: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 87 out of 100
- ESM1b (LLR): 86 out of 100
- MetaLR: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 79 out of 100
- EVE: 74 out of 100
- Pangolin: 56 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Nonsyndromic genetic hearing loss variants (38 pathogenic / likely pathogenic).
- Rare genetic deafness also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Nonsyndromic genetic hearing loss variants (25 pathogenic / likely pathogenic).
- Mutilating keratoderma also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Nonsyndromic genetic hearing loss variants (15 pathogenic / likely pathogenic).
- Ichthyosis, hystrix-like, with hearing loss also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Nonsyndromic genetic hearing loss variants (13 pathogenic / likely pathogenic).
- Autosomal dominant keratitis-ichthyosis-hearing loss syndrome also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Nonsyndromic genetic hearing loss variants (13 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to OTOF variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (21 pathogenic / likely pathogenic).
- Auditory neuropathy also has ClinVar records linked to OTOF variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (10 pathogenic / likely pathogenic).
- Bilateral sensorineural hearing impairment also has ClinVar records linked to OTOF variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (6 pathogenic / likely pathogenic).
- Hearing loss also has ClinVar records linked to OTOF variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (6 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to TMC1 variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (15 pathogenic / likely pathogenic).
- Hearing loss also has ClinVar records linked to TMC1 variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (7 pathogenic / likely pathogenic).
- Autosomal dominant nonsyndromic hearing loss also has ClinVar records linked to TMC1 variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (4 pathogenic / likely pathogenic).
- Usher syndrome also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (80 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (26 pathogenic / likely pathogenic).
- Rare genetic deafness also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (23 pathogenic / likely pathogenic).
- Autosomal dominant nonsyndromic hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (13 pathogenic / likely pathogenic).
- Hearing loss also has ClinVar records linked to MYO7A variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (4 pathogenic / likely pathogenic).
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to MYO15A variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (57 pathogenic / likely pathogenic).
- Rare genetic deafness also has ClinVar records linked to MYO15A variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (5 pathogenic / likely pathogenic).
- Autosomal dominant nonsyndromic hearing loss also has ClinVar records linked to TECTA variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (15 pathogenic / likely pathogenic).
- Rare genetic deafness also has ClinVar records linked to TECTA variants; they fall mostly in different places as the Nonsyndromic genetic hearing loss variants (3 pathogenic / likely pathogenic).
Diseases related to Nonsyndromic genetic hearing loss
- Rare genetic deafness, also linked to GJB2, KCNQ4, MYO15A, MYO6 and 4 more
- Hearing loss, also linked to GJB2, MYO15A, MYO6, MYO7A and 3 more
- Monogenic hearing loss, also linked to GJB2, KCNQ4, MYO15A, MYO6 and 3 more
- Autosomal recessive nonsyndromic hearing loss, also linked to GJB2, MYO15A, MYO7A, OTOF and 2 more
- Autosomal dominant nonsyndromic hearing loss, also linked to GJB2, KCNQ4, MYO6, MYO7A and 2 more
- Deafness, also linked to GJB2, MYO15A, MYO7A, OTOF and 2 more
- Bilateral sensorineural hearing impairment, also linked to KCNQ4, OTOF and TMC1
- Ear malformation, also linked to MYO15A, MYO7A and TECTA
- Auditory neuropathy, also linked to MYO7A and OTOF
- Retinitis pigmentosa, also linked to MYO7A
- Noonan syndrome, also linked to GJB2
- Usher syndrome, also linked to MYO7A
Frequently asked questions
Which genes have records linked to Nonsyndromic genetic hearing loss?
This view contains 8 analyzed proteins: GJB2, OTOF, TMC1, MYO7A, MYO15A and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 51 pathogenic or likely pathogenic variants, 20 variants of uncertain significance and 14 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 127 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center